Section R156-17b-102: Definitions are added as follows: 1) define the term "self-administered hormonal contraceptive" by reference to Section 26-62-102(9); 2) define the new "Utah Hormonal Contraceptive Self-Screening Risk Assessment Questionnaire" as the self-screening risk assessment questionnaire that is approved by the Division pursuant to Section 26-62-106; 3) define the "professional entry degree" required for licensure under Subsection 58-17b-303(1)(f) as the professional entry degree that was offered by the applicant's Accreditation Council on Pharmacy Education (ACPE) accredited school or college of pharmacy in the applicant's year of graduation, either a baccalaureate in Pharmacy (BSPharm) or a doctorate in pharmacy (PharmD); and 4)update the United States Pharmacopeia-National Formulary to USP 41-NF 36 and incorporate it into rule by reference. Section R156-17b-303b: These proposed amendments delete duplicative provisions, and update and clarify pharmacy internship standards required for licensure as a pharmacist, in accordance with the ACPE's current 2016 Standards. Section R156-17b-303c: This proposed amendment increases from two to three the number of North American Pharmacy Licensing Exam (NAPLEX) or Multistate Jurisprudence Exam (MPJE) failures allowed to an applicant, before the applicant must meet with the Board to request an additional authorization to test. Section R156-17b-304: These proposed amendments make non-substantive formatting changes for clarity and provide consistency for temporary licenses with licensure examination requirements. Section R156-17b-308: These proposed amendments clarify and update renewal and reinstatement procedures. In particular, as allowed by Subsection 58-1-308(5)(a)(ii)(B) and Section 58-17b-506, these proposed amendments will allow former Utah licensees whose licenses expired while active and in good standing, easier re-entry into practice by extending their permissible reinstatement period from two years to eight years. This means that if these former licensees meet continuing education and certain other requirements, they may apply for reinstatement instead of being required to submit a new application for licensure complete with all supporting documents as is required of an individual making an initial application for license and demonstrating they meet all current qualifications for licensure. Section R156-17b-309: These proposed amendments clarify and update continuing education requirements as follows: 1) make non-substantive formatting changes throughout for clarity; 2) for pharmacists, update continuing education standards and topics by deleting the old topics of "drug therapy or patient management", and substituting the current topics of "disease state management/drug therapy, AIDS/HIV therapy, or patient safety"; 3) for pharmacy technicians, reduce the eight-hour "live or technology-enabled participation" requirement to six hours; 4) for pharmacists, clarify existing continuing education requirements regarding individual licensee practices (such as requiring two continuing education hours in topics related to long-acting injectables if the licensee will be providing administration of long-acting injectable drug therapy, and requiring two hours in topics related to hormonal contraceptive therapy if the licensee will be prescribing and dispensing a self-administered hormonal contraceptive); 5) add additional options for fulfilling continuing education requirements, including allowing one "live" continuing education (CE) hour for attending one Utah State Board of Pharmacy meeting, up to a maximum of two CE hours during each two-year period, and allowing two CE hours for each hour of lecturing or instructing a CE course or teaching in the licensee's profession, up to a maximum of ten CE hours during each two-year period; 6) require licensees to prove compliance with their continuing education requirements through registration with the free National Association of Boards of Pharmacy (NABP) e-profile CPE Monitor plan, or the NABP CPE Monitor Plus plan, and by maintaining a certificate of completion or other adequate documentation for CE that cannot be tracked by the NABP plan. Section R156-17b-402: These proposed amendments add to the fine and citation schedule "failing to act in accordance with Title 26, Chapter 62, Family Planning Access Act, when dispensing a self-administered hormonal contraceptive under a standing order, in violation of 58-17b-502(14)". Section R156-17b-610: These proposed amendments provide guidelines for patient counseling by a pharmacist or pharmacy intern who dispenses a self-administered hormonal contraceptive. The guidelines require the pharmacist or pharmacy intern to obtain a completed Utah Hormonal Contraceptive Self-Screening Risk Assessment Questionnaire, and provide the written information and counseling described in Section 26-62-106. Section R156-17b-621b: This proposed amendment establishes the operating standards for pharmacist and pharmacy intern dispensing of a self-administered hormonal contraceptive. These standards require special initial training and continuing education, and use of the new Utah Hormonal Contraceptive Self-Screening Risk Assessment Questionnaire adopted by the Division in collaboration with the Board.